We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
iShares US Technology ETF
IYW
$25.2B
| $2.64M | 0.02% |
31,021
+2,061
| +7% | +$165K |
|
452
S&P Global
SPGI
$120B
| $2.6M | 0.02% |
7,906
+1,325
| +20% | +$447K |
|
453
Hercules Capital
HTGC
$3.23B
| $2.59M | 0.02% |
179,828
-3,907
| -2% | -$49.7K |
|
454
Lloyds Banking Group
LYG
$91.3B
| $2.59M | 0.02% |
1,323,045
-67,733
| -5% | -$114K |
|
455
Fidelity High Dividend ETF
FDVV
$10.4B
| $2.58M | 0.02% |
80,500
| – | – |
|
456
US Bancorp
USB
$99.6B
| $2.57M | 0.02% |
55,191
-1,082
| -2% | -$45.8K |
|
457
Vanguard Industrials ETF
VIS
$8.39B
| $2.55M | 0.02% |
15,029
+1,374
| +10% | +$220K |
|
458
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $2.55M | 0.02% |
30,783
+1,477
| +5% | +$122K |
|
459
ADC Therapeutics
ADCT
$144M
| $2.54M | 0.02% |
+79,397
| New | +$2.6M |
|
460
TransDigm Group
TDG
$67.7B
| $2.52M | 0.02% |
4,082
-80
| -2% | -$44K |
|
461
Newmont
NEM
$119B
| $2.52M | 0.02% |
42,149
-324
| -0.8% | -$20K |
|
462
Cigna
CI
$74.6B
| $2.52M | 0.02% |
12,090
-468
| -4% | -$91.8K |
|
463
Monster Beverage
MNST
$88.5B
| $2.52M | 0.02% |
54,418
+1,922
| +4% | +$80.8K |
|
464
Sunrun
RUN
$2.46B
| $2.51M | 0.02% |
36,178
+20,378
| +129% | +$1.27M |
|
|
GWPH
465
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.51M | 0.02% |
21,718
+6,019
| +38% | +$674K |
|
466
ARK Innovation ETF
ARKK
$6.31B
| $2.49M | 0.02% |
20,023
+11,791
| +143% | +$1.28M |
|
467
Dow Inc
DOW
$21.2B
| $2.49M | 0.02% |
44,918
-29,179
| -39% | -$1.51M |
|
468
Barron's 400 ETF
BFOR
$239M
| $2.48M | 0.02% |
199,552
+8
| +0% | +$93 |
|
469
Phillips 66
PSX
$81.4B
| $2.48M | 0.02% |
35,405
-284
| -0.8% | -$16.7K |
|
470
Akamai
AKAM
$15.9B
| $2.47M | 0.02% |
23,516
+4,621
| +24% | +$484K |
|
471
iShares Expanded Tech Sector ETF
IGM
$10.7B
| $2.47M | 0.02% |
42,294
+3,264
| +8% | +$179K |
|
|
ALTA
472
DELISTED
Altabancorp
ALTA
| $2.45M | 0.02% |
87,926
+59,694
| +211% | +$1.52M |
|
473
VanEck Intermediate Muni ETF
ITM
$2.15B
| $2.45M | 0.02% |
47,026
+2,504
| +6% | +$129K |
|
|
PFPT
474
DELISTED
Proofpoint, Inc.
PFPT
| $2.44M | 0.02% |
17,898
+6,521
| +57% | +$715K |
|
475
Centene
CNC
$32.5B
| $2.44M | 0.02% |
40,623
+25,935
| +177% | +$1.65M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.